Sanofi has firmed up its position in the red-hot area of radiopharmaceuticals for cancer with the purchase of a €300 million ($325 million) stake in Orano Med, a subsidiary of French nuclear ...
On September 12, 2024, Orano Med signed a licensing agreement with Sanofi on the marketing rights for AlphaMedix, with Orano Med remaining responsible for its production thanks to its global ...
DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on ...
PARIS, Feb 19 (Reuters) - French nuclear fuels company Orano is looking to increase output of uranium from new mines in Mongolia and elsewhere to meet rising demand from the nuclear power industry ...
On September 12, 2024, Orano Med signed a licensing agreement with Sanofi on the marketing rights for AlphaMedix, with Orano Med remaining responsible for its production thanks to its global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback